Thus, our findings suggest the interesting idea that the promising anti-leukemic effects of Celastrol that we have previously described [25] might be due to the abrogation of Myb, C/EBPβ and p300 function at super-enhancers in AML cells. The gene discussed is CEBPB; the disease is acute myeloid leukemia.